265 results on '"Sciuto, R."'
Search Results
2. DOSIMETRY OF HEPATIC METASTASES AND LIVER FOR PATIENTS UNDERGOING HO-166 MICROSPHERES RADIOEMBOLIZATION
3. DOSIMETRY AND SURVIVAL IN UNRESECTABLE PRIMARY HEPATOCELLULAR CARCINOMA PATIENTS UNDERGOING SELECTIVE INTERNAL RADIOTHERAPY WITH RESIN 90Y: THE INTERIM ANALYSIS OF A RANDOMIZED CLINICAL TRIAL
4. Introduction
5. Voltaire philosophe: un architecte de la pensée
6. PC-07.2 - AN INTERNET OF THINGS (IOT) SYSTEM TO REPORT ON ABNORMAL EVENTS IN NUCLEAR MEDICINE THERAPY PATIENT ROOMS
7. MO-05.4 - DOSIMETRY OF HEPATIC METASTASES AND LIVER FOR PATIENTS UNDERGOING HO-166 MICROSPHERES RADIOEMBOLIZATION
8. CO-08.1 - DOSIMETRY AND SURVIVAL IN UNRESECTABLE PRIMARY HEPATOCELLULAR CARCINOMA PATIENTS UNDERGOING SELECTIVE INTERNAL RADIOTHERAPY WITH RESIN 90Y: THE INTERIM ANALYSIS OF A RANDOMIZED CLINICAL TRIAL
9. Bringing together the Essay and the Second Treatise: d’Holbach interpreter of Locke
10. Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study
11. Bridging and downstaging to transplantation in HCC
12. Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution
13. A prospective study assessing the post-prostatectomy detection rate of a presumed local failure at mpMR with 18F-choline, 64Cu-Cl2 or 64Cu-PSMA PET/CT
14. Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study
15. Radiopharmaceutical therapy of bone metastases with 89SrCl2, 186Re-HEDP and 153Sm-EDTMP: a dosimetric study using Monte Carlo simulation
16. HIGH-RISK PATIENTS WITH DIFFERENTIATED THYROID CANCER T4 PRIMARY TUMORS ACHIEVE REMNANT ABLATION EQUALLY WELL USING RECOMBINANT HUMAN TSH OR THYROID HORMONE WITHDRAWAL: OP21
17. Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma
18. Experimental evidence of mounting grooves and serration patterns on fin lines characteristics
19. Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy
20. 99Tcm-MIBI scintimammography in 300 consecutive patients: Factors that may affect accuracy
21. Myocardial 123I-MIBG kinetics in acutely hypothyroid patients with differentiated thyroid carcinoma
22. Diderot and d’Holbach: a theory of determinism
23. Comparison 18F-FDG-PET/CT criteria for prediction of therapy response and clinical outcome in patients with metastatic melanoma treated with ipilimumab and PD-1 inhibitors
24. Delivery of selective internal radiation therapy complicated by variant hepatic vascular anatomy
25. 86. Biological effects evaluation in peripheral blood lymphocytes from patients undergoing radium-223 (223RaCl2) therapy
26. The predictive value of 18F-FDG PET/CT after ipilimumab for treatment response evaluation in metastatic melanoma patients
27. Radiosensitization with low-dose carboplatin enhances pain palliation in radioisotope therapy with strontium-89
28. Somatostatin receptor imaging in CNS tumours using 111In-octreotide
29. Somatostatin receptors in meningiomas: a scintigraphic study using 111In-DTPA-d-Phe-1-octreotide
30. Somatostatin receptor imaging in small cell lung cancer using 111In-DTPA-octreotide: a preliminary study
31. Synchronous triple thymoma and true thymic hyperplasia simultaneously detected by 18F FDG PET-CT
32. Combination of long term N-Acetylcysteine and Ursodeoxycolic Acid in NASH: a multicenter randomized control trial
33. First results from bone histology of the dwarf elephant Palaeoloxodon falconeri from Sicily
34. Evaluation of safety, tolerability and overall survival following whole-liver, lobar or segmental radioembolization in unresectable hepatocellular carcinoma (HCC)
35. Survival and tolerability following 90Y-resin microsphere radioembolization in patients with unresectable BCLC stage C hepatocellular carcinoma (HCC)
36. 1261P - Comparison 18F-FDG-PET/CT criteria for prediction of therapy response and clinical outcome in patients with metastatic melanoma treated with ipilimumab and PD-1 inhibitors
37. Phase II multicenter study of 90yttrium resin microspheres for patients with unresectable colorectal liver metastases who had failed prior oxaliplatin- and irinotecan-based regimens
38. ¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients
39. Clinical safety and efficacy of 90yttrium resin microspheres alone in unresectable, heavily pre-treated colorectal liver metastases: results of a phase II trial
40. Phase II Evaluation of 90yttrium Resin microspheres (Sir-Spheres®) monotherapy in unresectable, plus heavily pre-treated colorectal liver metastases
41. Phase II Prospective Evaluation of The Clinical Efficacy and Safety of 90yttrium-Labelled Resin Microspheres (Sir-Spheres®) in unresectable, Highly Pre-Treated Colorectal Liver Metastases
42. 67P - The predictive value of 18F-FDG PET/CT after ipilimumab for treatment response evaluation in metastatic melanoma patients
43. Evaluation of metabolic status in amiodarone-induced thyroid disorders: plasma coenzyme Q10 determination
44. Brown adipose tissue in an italian adult population
45. Tc-99m-MIBI scintimammography using a dedicated nuclear mammograph
46. Coarctation of the aorta with aortic arch hypoplasia in newborn with partial trisomy 11q associated to 4q interstitial deletion
47. Phase II evaluation of 90yttrium resin microspheres (sir-spheres) monotherapy in unresectable, heavily pre-treated colorectal liver metastaseses
48. A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90 Yttrium SIR-spheres in unresectable colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates
49. Italian Society of Locoregional therapies in Oncology. A multic entric phase II clinica trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to IV chemotherapy:preliminary results on toxicity and response rates
50. 'Preliminary study of tumor size response to low and high doses cabergolina therapy in clinically non-functioning macroadenomas with different D2 receptor expression detected with 123-I-IBZM pituitary scintigraphy'
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.